Transanal Local Excision for Distal Rectal Cancer and Incomplete Response to Neoadjuvant Chemoradiation - Does Baseline Staging Matter?

Imagem de Miniatura
Arquivos
art_PEREZ_Transanal_Local_Excision_for_Distal_Rectal_Cancer_and_2014.PDF (286.36 KB)
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
PEREZ, Rodrigo O.
JULIAO, Guilherme P. Sao
PROSCURSHIM, Igor
FIGUEIREDO, Marleny N.
FERNANDEZ, Laura M.
Citação
DISEASES OF THE COLON & RECTUM, v.57, n.11, p.1253-1259, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Local excision may offer the possibility of organ preservation for the management of select patients after neoadjuvant chemoradiation. The oncological outcomes of this strategy have been largely associated with the risk of nodal metastases. Therefore, in addition to final ypT status, baseline staging has been suggested to potentially influence the outcomes of this treatment modality. OBJECTIVE: The aim of this study is to compare the pathological and oncological outcomes of patients following neoadjuvant chemoradiation and incomplete clinical response managed by transanal endoscopic microsurgery according to baseline staging. DESIGN: This study is a retrospective review of prospectively collected data. SETTINGS: The study was conducted at a single center. PATIENTS: Forty-six patients with distal rectal cancer cT2-4N0- 2M0 underwent 5-fluorouracil-based neoadjuvant chemoradiation. Assessment of response was performed at least 8 weeks from radiotherapy completion. Patients with a complete clinical response were not operated on immediately. Patients with an incomplete clinical response were managed by surgery. Those with small (<= 3 cm) residual cancers (ycT1-2N0M0) were managed by transanal endoscopic microsurgery. MAIN OUTCOME MEASURES: Patients undergoing local excision following chemoradiation were compared according to baseline staging. RESULTS: Fifteen patients (32%) were cT2N0 at baseline. Final ypT status was ypT0 in 3 (20%) patients, ypT1 in 2 (13%) patients, ypT2 in 9 (60%) patients, and ypT3 in 1 (7%) patient. There were no differences in final ypT status in comparison with patients with baseline cT3-4 or cN+ undergoing chemoradiation followed by transanal endoscopic microsurgery (p = 0.38). Local recurrence was observed in 1 patient with baseline cT2N0 (7%) and in 7 patients (23%) with stage II and II (p = 0.18). LIMITATIONS: This study was limited by the short follow-up, its limited sample size, and its retrospective and nonrandomized nature. CONCLUSIONS: Patients with baseline cT2N0 that do not develop complete response to chemoradiation (ycT02N0; <= 3 cm) frequently present unfavorable pathological features for transanal local excision (ypT2 or 3 in >66%). In the presence of incomplete clinical response following chemoradiation, patients with baseline cT2N0 have pathological and oncological outcomes similar to patients with baseline stage II or II and are probably not ideal candidates for local excision (see Video, Supplemental Digital Content 1, http://links.lww.com/DCR/A159).
Palavras-chave
Rectal cancer, Neoadjuvant chemoradiation, Transanal endoscopic microsurgery, Initial staging, Recurrence
URI
https://observatorio.fm.usp.br/handle/OPI/8430
Referências
  1. Bosset JF, 2014, LANCET ONCOL, V15, P184, DOI 10.1016/S1470-2045(13)70599-0
  2. Bosset JF, 2005, J CLIN ONCOL, V23, P5620, DOI 10.1200/JCO.2005.02.113
  3. Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829
  4. Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747
  5. Bujko K, 2013, RADIOTHER ONCOL, V106, P198, DOI 10.1016/j.radonc.2012.12.005
  6. Engelen SME, 2010, DIS COLON RECTUM, V53, P979, DOI 10.1007/DCR.0b013e3181dc64dc
  7. Garcia-Aguilar J, 2013, DIS COLON RECTUM, V56, P1, DOI 10.1097/DCR.0b013e318273f58c
  8. Habr-Gama A, 2011, SEMIN RADIAT ONCOL, V21, P234, DOI 10.1016/j.semradonc.2011.02.010
  9. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  10. Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e
  11. Habr-Gama A, 2010, DIS COLON RECTUM, V53, P1692, DOI 10.1007/DCR.0b013e3181f42b89
  12. Habr-Gama A, 2014, MINIM INVASIV THER, V23, P63, DOI 10.3109/13645706.2014.893891
  13. Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012
  14. Hayden DM, 2012, DIS COLON RECTUM, V55, P1206, DOI 10.1097/DCR.0b013e318269fdb3
  15. Hompes R, 2013, COLORECTAL DIS, V15, pe576, DOI 10.1111/codi.12381
  16. Landmann RG, 2007, DIS COLON RECTUM, V50, P1520, DOI 10.1007/s10350-007-9019-0
  17. Lezoche E, 2012, BRIT J SURG, V99, P1211, DOI 10.1002/bjs.8821
  18. Lezoche E, 1998, SURG LAPAROSC ENDOSC, V8, P249, DOI 10.1097/00019509-199808000-00001
  19. Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
  20. Marks JH, 2009, SURG ENDOSC, V23, P1081, DOI 10.1007/s00464-009-0326-5
  21. Marks JH, 2011, SURG ONCOL CLIN N AM, V20, P501, DOI 10.1016/j.soc.2011.01.008
  22. Park IJ, 2013, DIS COLON RECTUM, V56, P135, DOI 10.1097/DCR.0b013e318278ff8a
  23. Perez RO, 2013, DIS COLON RECTUM, V56, P6, DOI 10.1097/DCR.0b013e318273f56f
  24. Perez RO, 2014, J SURG ONCOL, V109, P853, DOI 10.1002/jso.23571
  25. Perez RO, 2007, J GASTROINTEST SURG, V11, P1431, DOI 10.1007/s11605-007-0271-3
  26. Perez RO, 2011, DIS COLON RECTUM, V54, P545, DOI 10.1007/DCR.0b013e3182083b84
  27. Perez RO, 2009, DIS COLON RECTUM, V52, P1278, DOI 10.1007/DCR.0b013e3181a0af4b
  28. Pucciarelli S, 2013, DIS COLON RECTUM, V56, P1349, DOI 10.1097/DCR.0b013e3182a2303e
  29. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  30. Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836
  31. Smith FM, 2010, BRIT J SURG, V97, P1752, DOI 10.1002/bjs.7251
  32. Yeo SG, 2010, JPN J CLIN ONCOL, V40, P754, DOI 10.1093/jjco/hyq062

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - ODS/03